Tau species has potential for Alzheimer disease blood test

Ian Fyfe¹

Affiliations

Comment

Ian Fyfe. Nat Rev Neurol. 2020 Oct.

. 2020 Oct;16(10):521.

doi: 10.1038/s41582-020-0401-z.

Ian Fyfe¹

No abstract available

Comment on

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y, Serrano GE, Leuzy A, Mattsson-Carlgren N, Strandberg O, Smith R, Villegas A, Sepulveda-Falla D, Chai X, Proctor NK, Beach TG, Blennow K, Dage JL, Reiman EM, Hansson O. Palmqvist S, et al. JAMA. 2020 Aug 25;324(8):772-781. doi: 10.1001/jama.2020.12134. JAMA. 2020. PMID: 32722745 Free PMC article.
Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease.
Barthélemy NR, Horie K, Sato C, Bateman RJ. Barthélemy NR, et al. J Exp Med. 2020 Nov 2;217(11):e20200861. doi: 10.1084/jem.20200861. J Exp Med. 2020. PMID: 32725127 Free PMC article.

1. Barthélemy, N. R. et al. Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease. J. Exp. Med. 217, e20200861 (2020) - DOI
1. Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA https://doi.org/10.1001/jama.2020.12134 (2020) - DOI - PubMed